Implanted Devices Drive Electrostimulation Market

These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm.

Among the technologies that are represented in the electrical and magnetic stimulation market are electromuscular stimulation (EMS), which can aid in the recuperation of overworked muscles; tanscranial magnetic stimulation (TMS), a noninvasive technique that uses an electromagnet placed on the patient's scalp to alter brain activity; and transcutaneous electrical nerve stimulation (TENS), which is commonly used for pain management. The market also includes a range of implanted technologies, such as Vagus Nerve Stimulation (VNS) and Cardiac ResynchronizationTherapy (CRT).

Several implanted electrode therapeutic systems have recently emerged in the market and the potential has clearly caught the eye of pharmaceutical and microelectronics companies, which are actively expanding their stake in electrode therapeutics through research, collaborations, and acquisitions. According to the report, these actions will push more applications into the marketplace, and medical insurance will likely recognize a long-term savings for electronic treatment of chronic and debilitating conditions.

“During the previous years, repetitive TMS has received a growing attention in the popular and scientific media, and the market forecasts reflect growing professional medical acceptance,” said Bruce Carlson, publisher of Kalorama Information. “Combined with new telemedicine strategies, implanted sensors, and drug delivery systems, electrical and magnetic neurostimulation can usher in a new wave of care for the chronically ill.”

According to Kalorama Information, the electrical and magnetic neurostimulation market reached revenues of USD 16.3 billion in 2011. Major companies operating in the market include Bioness (Valencia, CA, USA), Dynatronics, Medtronic, Noraxon (Scottsdale, AZ, USA), Smith & Nephew, Thought Technology and many more.

Related Links:
Kalorama Information
Bioness
Noraxon